학술논문

Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.
Document Type
article
Author
Zhang, Yan DoraHurson, Amber NZhang, HaoyuChoudhury, Parichoy PalEaston, Douglas FMilne, Roger LSimard, JacquesHall, PerMichailidou, KyriakiDennis, JoeSchmidt, Marjanka KChang-Claude, JennyGharahkhani, PuyaWhiteman, DavidCampbell, Peter THoffmeister, MichaelJenkins, MarkPeters, UlrikeHsu, LiGruber, Stephen BCasey, GrahamSchmit, Stephanie LO'Mara, Tracy ASpurdle, Amanda BThompson, Deborah JTomlinson, IanDe Vivo, ImmaculataLandi, Maria TeresaLaw, Matthew HIles, Mark MDemenais, FlorenceKumar, RajivMacGregor, StuartBishop, D TimothyWard, Sarah VBondy, Melissa LHoulston, RichardWiencke, John KMelin, BeatriceBarnholtz-Sloan, JillKinnersley, BenWrensch, Margaret RAmos, Christopher IHung, Rayjean JBrennan, PaulMcKay, JamesCaporaso, Neil EBerndt, Sonja IBirmann, Brenda MCamp, Nicola JKraft, PeterRothman, NathanielSlager, Susan LBerchuck, AndrewPharoah, Paul DPSellers, Thomas AGayther, Simon APearce, Celeste LGoode, Ellen LSchildkraut, Joellen MMoysich, Kirsten BAmundadottir, Laufey TJacobs, Eric JKlein, Alison PPetersen, Gloria MRisch, Harvey AStolzenberg-Solomon, Rachel ZWolpin, Brian MLi, DonghuiEeles, Rosalind AHaiman, Christopher AKote-Jarai, ZsofiaSchumacher, Fredrick RAl Olama, Ali AminPurdue, Mark PScelo, GhislaineDalgaard, Marlene DGreene, Mark HGrotmol, TomKanetsky, Peter AMcGlynn, Katherine ANathanson, Katherine LTurnbull, ClareWiklund, FredrikBreast Cancer Association Consortium (BCAC)Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON)Colon Cancer Family Registry (CCFR)Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT)Endometrial Cancer Association Consortium (ECAC)Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)Melanoma Genetics Consortium (GenoMEL)Glioma International Case-Control Study (GICC)International Lung Cancer Consortium (ILCCO)Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) ConsortiumInternational Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies (InterLymph)Ovarian Cancer Association Consortium (OCAC)Oral Cancer GWASPancreatic Cancer Case-Control Consortium (PanC4)Pancreatic Cancer Cohort Consortium (PanScan)Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL)
Source
Nature communications. 11(1)
Subject
Breast Cancer Association Consortium
Barrett’s and Esophageal Adenocarcinoma Consortium
Colon Cancer Family Registry
Transdisciplinary Studies of Genetic Variation in Colorectal Cancer
Endometrial Cancer Association Consortium
Genetics and Epidemiology of Colorectal Cancer Consortium
Melanoma Genetics Consortium
Glioma International Case-Control Study
International Lung Cancer Consortium
Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium
International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies
Ovarian Cancer Association Consortium
Oral Cancer GWAS
Pancreatic Cancer Case-Control Consortium
Pancreatic Cancer Cohort Consortium
Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome
Renal Cancer GWAS
Testicular Cancer Consortium
Animals
Humans
Neoplasms
Genetic Predisposition to Disease
Incidence
Risk Assessment
Risk Factors
Multifactorial Inheritance
Polymorphism
Single Nucleotide
Models
Genetic
Female
Male
Genome-Wide Association Study
Human Genome
Prevention
Cancer
Prostate Cancer
Genetics
Urologic Diseases
2.1 Biological and endogenous factors
Language
Abstract
Genome-wide association studies (GWAS) have led to the identification of hundreds of susceptibility loci across cancers, but the impact of further studies remains uncertain. Here we analyse summary-level data from GWAS of European ancestry across fourteen cancer sites to estimate the number of common susceptibility variants (polygenicity) and underlying effect-size distribution. All cancers show a high degree of polygenicity, involving at a minimum of thousands of loci. We project that sample sizes required to explain 80% of GWAS heritability vary from 60,000 cases for testicular to over 1,000,000 cases for lung cancer. The maximum relative risk achievable for subjects at the 99th risk percentile of underlying polygenic risk scores (PRS), compared to average risk, ranges from 12 for testicular to 2.5 for ovarian cancer. We show that PRS have potential for risk stratification for cancers of breast, colon and prostate, but less so for others because of modest heritability and lower incidence.